Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Haberl

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Cancers|October 16, 2024
Systemic Metabolic and Volumetric Assessment via Whole-Body [<sup>18</sup>F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell CarcinomaJosef Yu, Clemens Spielvogel, David Haberl, et al.
Theranostics|September 6, 2024
A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics studyJing Ning, Clemens P Spielvogel, David Haberl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2025
Generative artificial intelligence enables the generation of bone scintigraphy images and improves generalization of deep learning models in data-constrained environmentsDavid Haberl, Jing Ning, Kilian Kluge, et al.
Molecular Cancer|March 28, 2026
[<sup>18</sup>F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinomaStefan Stoiber, Daniel Pölöske, Clemens P Spielvogel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2025
Impact of disease-modifying therapy on [<sup>99m</sup>Tc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligenceClemens P Spielvogel, Markus Köfler, Zewen Jiang, et al.
The Lancet. Digital Health|March 22, 2024
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation studyClemens P Spielvogel, David Haberl, Katharina Mascherbauer, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Cancers|October 16, 2024
Systemic Metabolic and Volumetric Assessment via Whole-Body [<sup>18</sup>F]FDG-PET/CT: Pancreas Size Predicts Cachexia in Head and Neck Squamous Cell CarcinomaJosef Yu, Clemens Spielvogel, David Haberl, et al.
Theranostics|September 6, 2024
A novel assessment of whole-mount Gleason grading in prostate cancer to identify candidates for radical prostatectomy: a machine learning-based multiomics studyJing Ning, Clemens P Spielvogel, David Haberl, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2025
Generative artificial intelligence enables the generation of bone scintigraphy images and improves generalization of deep learning models in data-constrained environmentsDavid Haberl, Jing Ning, Kilian Kluge, et al.
Molecular Cancer|March 28, 2026
[<sup>18</sup>F]FDG PET/CT multiomics identifies Hedgehog-driven HPV-negative head and neck squamous cell carcinomaStefan Stoiber, Daniel Pölöske, Clemens P Spielvogel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 29, 2025
Impact of disease-modifying therapy on [<sup>99m</sup>Tc]Tc-DPD SPECT/CT markers in transthyretin cardiac amyloidosis enabled by artificial intelligenceClemens P Spielvogel, Markus Köfler, Zewen Jiang, et al.
The Lancet. Digital Health|March 22, 2024
Diagnosis and prognosis of abnormal cardiac scintigraphy uptake suggestive of cardiac amyloidosis using artificial intelligence: a retrospective, international, multicentre, cross-tracer development and validation studyClemens P Spielvogel, David Haberl, Katharina Mascherbauer, et al.
Pageof 3